NAM
IRWD icon

NorthCrest Asset Manangement’s Ironwood Pharmaceuticals IRWD Stock Holding History

NorthCrest Asset Manangement’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.6K Sell
14,476
-2,923
-17% -$11.3K ﹤0.01% 900
2026
Q1 		$61.6K Buy
17,399
+4,242
+32% +$17.4K ﹤0.01% 755
2025
Q4 		$60.4K Buy
13,157
+155
+1% +$403 ﹤0.01% 812
2025
Q3 		$19.8K Buy
13,002
+1,881
+17% +$1.95K ﹤0.01% 742
2025
Q2 		$8.52K Buy
+11,121
New +$8.73K ﹤0.01% 623

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

NorthCrest Asset Manangement's IRWD Position: Q2 2026 in Review

NorthCrest Asset Manangement reduced its Ironwood Pharmaceuticals (IRWD) stake by 17% in Q2 2026, selling an estimated $11.3K and leaving 14,476 shares worth $67.6K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

NorthCrest Asset Manangement first reported a position in IRWD in Q2 2025 and has held it in 5 quarters since. 39 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • NorthCrest Asset Manangement held 14,476 shares of Ironwood Pharmaceuticals worth $67.6K as of Q2 2026.
  • NorthCrest Asset Manangement sold 2,923 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $11.3K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #900 holding.
  • NorthCrest Asset Manangement first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 39 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.